Johnson & Johnson hopes to begin late-stage coronavirus vaccine trial ahead of schedule in September

Johnson & Johnson said it expects to begin a late-stage human trial for a potential coronavirus vaccine in late September, ahead of schedule.

from Health and Science https://ift.tt/3j2UOcm
https://ift.tt/eA8V8J
https://ift.tt/2zIUzyH